Fit for the future The GLP-1 boom is likely to serve as a useful case study for the pharmaceutical industry on various levels
If you're concerned about continuing treatment, your GP can explain the NHS prescribing guidelines, availability of alternatives, and any applicable prescription charges or exemptions
In the STEP trial published in the New England Journal of Medicine in 2021, adults with obesity who received semaglutide along with lifestyle guidance achieved significant reductions in body weight over 68 weeks
Meghan has observed that reactions often shift as patients increase their medication doses
Ultimately, the decision between tirzepatide and semaglutide should be made as part of a broader weight management strategy, taking into account lifestyle modifications, potential risks, and long-term sustainability
Publisher Responsibility Disclaimer: The publisher has made reasonable efforts to present accurate information based on available source material at the time of writing